Veracyte Correlations
VCYT Stock | USD 23.51 0.48 2.08% |
The current 90-days correlation between Veracyte and Verve Therapeutics is 0.2 (i.e., Modest diversification). The correlation of Veracyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Veracyte Correlation With Market
Very weak diversification
The correlation between Veracyte and DJI is 0.58 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and DJI in the same portfolio, assuming nothing else is changed.
Moving against Veracyte Stock
0.86 | KB | KB Financial Group | PairCorr |
0.86 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.82 | WF | Woori Financial Group Earnings Call Today | PairCorr |
0.78 | AVAL | Grupo Aval | PairCorr |
0.68 | PFE | Pfizer Inc | PairCorr |
0.66 | KMDA | Kamada | PairCorr |
0.66 | FNMFO | Federal National Mortgage Earnings Call This Week | PairCorr |
0.59 | BAC-PL | Bank of America | PairCorr |
0.54 | NKTR | Nektar Therapeutics | PairCorr |
0.54 | RCUS | Arcus Biosciences | PairCorr |
0.54 | CGEN | Compugen | PairCorr |
0.44 | JNJ | Johnson Johnson | PairCorr |
0.36 | EVGN | Evogene | PairCorr |
0.87 | MSFT | Microsoft Earnings Call This Week | PairCorr |
0.85 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
0.84 | DIS | Walt Disney | PairCorr |
0.81 | IBM | International Business Earnings Call Today | PairCorr |
0.76 | AA | Alcoa Corp | PairCorr |
0.73 | AXP | American Express | PairCorr |
0.7 | CVX | Chevron Corp | PairCorr |
0.53 | INTC | Intel Earnings Call Tomorrow | PairCorr |
0.37 | WFC-PL | Wells Fargo | PairCorr |
0.31 | T | ATT Inc Earnings Call Today | PairCorr |
Related Correlations Analysis
0.94 | 0.79 | 0.51 | 0.86 | 0.97 | CRBU | ||
0.94 | 0.86 | 0.65 | 0.93 | 0.95 | CRSP | ||
0.79 | 0.86 | 0.4 | 0.79 | 0.81 | VERV | ||
0.51 | 0.65 | 0.4 | 0.73 | 0.56 | BEAM | ||
0.86 | 0.93 | 0.79 | 0.73 | 0.91 | PRME | ||
0.97 | 0.95 | 0.81 | 0.56 | 0.91 | SANA | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Veracyte Stock performing well and Veracyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Veracyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CRBU | 5.47 | 1.67 | 0.29 | 1.00 | 4.68 | 13.66 | 23.18 | |||
CRSP | 2.79 | 0.66 | 0.22 | 0.61 | 2.78 | 7.09 | 17.92 | |||
VERV | 4.63 | 1.78 | 0.39 | (55.16) | 3.00 | 8.49 | 83.78 | |||
BEAM | 2.83 | 0.21 | 0.07 | 0.30 | 4.24 | 6.28 | 26.62 | |||
PRME | 6.95 | 1.95 | 0.31 | 1.22 | 5.73 | 21.58 | 41.91 | |||
SANA | 4.86 | 1.68 | 0.44 | 1.39 | 3.21 | 12.50 | 31.62 |
Veracyte Corporate Management
Robert Brainin | Executive Officer | Profile | |
John Leite | Chief Business | Profile | |
Annie McGuire | Sr Counsel | Profile | |
Tracy Morris | VP Communications | Profile |